Second- and third-generation drugs for immuno-oncology treatment-The more the better?

δημοσιεύθηκε στο:  European Journal of Cancer
date of publication:  2017-02-10
main subject:  immuno-oncology

Article - wd:Q38881594

Welcome to Inventaire

the library of your friends and communities
learn more
you are offline